Too many people are missing out on a potentially life-changing opportunity to prevent cancer,” said Sir John Burn.

A large real-world Italian cohort study found that daily low-dose aspirin use significantly lowered the risk of developing ...

MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

That's according to a Bloomberg report, which claims Bayer has started the search for a successor well ahead of the end of Baumann's current contract in April 2024.

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.